EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The potential significance of hepcidin evaluation in progressive supranuclear palsy

Piotr Alster iD, Dagmara Otto-Ślusarczyk, Alicja Wiercińska-Drapało, Marta Struga, Natalia Madetko-Alster

Brain and Behavior · 2024-06 · 14 (6)

DOI: 10.1002/brb3.3552 ↗

At a glance

Journal article in Brain and Behavior, published online on 2024-06-21. Written by Piotr Alster and 4 co-authors. Institution: Department of Neurology, Medical University of Warsaw, Warsaw, Poland. Major MEDLINE topics: Hepcidins, Supranuclear Palsy, Progressive. Cited 13 times so far (Crossref); 18 references. The full text is freely available (open access, CC BY 4.0). Funded by: Warszawski Uniwersytet Medyczny.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Hepcidin is a peptide associated with controlling the distribution of iron in tissues. Growing interest is linked with its impact on neurodegenerative diseases, as disruption of the iron regulation may be considered an initiatory element of pathological protein accumulation. The possible impact of hepcidin was not previously sufficiently explored in progressive supranuclear palsy (PSP).

Methods

Twelve patients with PSP–Richardson's syndrome (PSP–RS), 12 with PSP‐Parkinsonism Predominant (PSP‐P), and 12 controls were examined using Unified Parkinson's Disease Rating Scale—III part (UPDRS‐III) in OFF stage and analyzed in the context of hepcidin levels in the serum.

Results

The work revealed increased levels of hepcidin in PSP–RS when compared to PSP‐P and controls. Moreover, hepcidin was found to be negatively correlated with UPDRS‐III results in PSP–RS, whereas positively in PSP‐P.

Conclusion

The work may suggest a possible impact of hepcidin in PSP, possibly differing depending on its subtype.

Subjects

MeSH terms (MEDLINE)

HepcidinsSupranuclear Palsy, ProgressiveAgedFemaleHumansMaleMiddle AgedSeverity of Illness Index

Author keywords

PSPatypical parkinsonismhepcidinprogressive supranuclear palsy

Substances

HepcidinsHAMP protein, human

Authors and institutions

  • Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
  • Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland.
  • Department of Infectious and Tropical Diseases and Hepatology, Medical University of Warsaw, Warsaw, Poland.

ORCID profiles: Piotr Alster

Funding

  • Warszawski Uniwersytet Medyczny

Cite

APA

Alster, P., Otto-Ślusarczyk, D., Wiercińska-Drapało, A., Struga, M., & Madetko-Alster, N. (2024). The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior, 14(6). https://doi.org/10.1002/brb3.3552

Vancouver

Alster P, Otto-Ślusarczyk D, Wiercińska-Drapało A, Struga M, Madetko-Alster N. The potential significance of hepcidin evaluation in progressive supranuclear palsy. Brain and Behavior. 2024;14(6). doi:10.1002/brb3.3552

BibTeX
@article{Alster2024,
  author = {Alster, Piotr and Otto-Ślusarczyk, Dagmara and Wiercińska-Drapało, Alicja and Struga, Marta and Madetko-Alster, Natalia},
  title = {The potential significance of hepcidin evaluation in progressive supranuclear palsy},
  journal = {Brain and Behavior},
  year = {2024},
  volume = {14},
  number = {6},
  doi = {10.1002/brb3.3552}
}
Start for free →